Agency Information Collection Activities: Submission for OMB Review; Comment Request, 31495-31496 [E8-12177]

Download as PDF jlentini on PROD1PC65 with NOTICES Federal Register / Vol. 73, No. 106 / Monday, June 2, 2008 / Notices Contact Person: Manana Sukhareva, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3214, MSC 7808, Bethesda, MD 20892, 301–435– 1116, sukharem@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Fellowships: Cell Biology. Date: July 10–11, 2008. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Jonathan Arias, PhD, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5170, MSC 7840, Bethesda, MD 20892, 301–435– 2406, ariasj@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Roadmap– R21 HTS Assays. Date: July 10, 2008. Time: 8 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: Doubletree Hotel, 8120 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: James J. Li, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5148, MSC 7849, Bethesda, MD 20892, 301–435–2417, lijames@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Nature’s Solutions. Date: July 10, 2008. Time: 2 p.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Joyce C. Gibson, DSC, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4130, MSC 7814, Bethesda, MD 20892, (301) 435– 4522, gibsonj@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Musculoskeletal Rehabilitation SBIR. Date: July 10–11, 2008. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Jo Pelham, BA, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4102, MSC 7814, Bethesda, MD 20892, (301) 435–1786, pelhamj@csrnih.gov. Name of Committee: AIDS and Related Research Integrated Review Group; AIDS Immunology and Pathogenesis Study Section. Date: July 11,2008. Time: 8 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. VerDate Aug<31>2005 19:06 May 30, 2008 Jkt 214001 Place: The Fairmont Hotel, 2401 M Street, NW., Washington, DC 20037. Contact Person: Shiv A. Prasad, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5220, MSC 7852, Bethesda, MD 20892, 301–443– 5779, prasads@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Small Business Hematology. Date: July 11, 2008. Time: 8 a.m. to 3 p.m. Agenda: To review and evaluate grant applications. Place: Hotel Lombardy, 2019 Pennsylvania Avenue, NW., Washington, DC 20006. Contact Person: Delia Tang, MD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4126, MSC 7802, Bethesda, MD 20892, 301–435–2506, tangd@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Predoctoral Fellowship to Promote Diversity in HealthRelated Research (DCPS). Date: July 11, 2008. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Savoy Suites, 2505 Wisconsin Avenue, NW., Washington, DC 20007. Contact Person: Gabriel B. Fosu, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3215, MSC 7808, Bethesda, MD 20892, (301) 435– 3562, fosug@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Cognition, Language, and Perception Fellowship Study Section. Date: July 11, 2008. Time: 8:30 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: The Fairmont Washington, D.C., 2401 M Street, NW., Washington, DC 20037. Contact Person: Dana Jeffrey Plude, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3176, MSC 7848, Bethesda, MD 20892, 301–435– 2309, pluded@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Alzheimer’s Disease Pilot Clinical Trials. Date: July 11, 2008. Time: 11 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting). Contact Person: Alfonso R. Latoni, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3182, MSC 7848, Bethesda, MD 20892, 301–435– 0913, latonia@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) PO 00000 Frm 00071 Fmt 4703 Sfmt 4703 31495 Dated: May 20, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–11790 Filed 5–30–08; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Agency Information Collection Activities: Submission for OMB Review; Comment Request Periodically, the Substance Abuse and Mental Health Services Administration (SAMHSA) will publish a summary of information collection requests under OMB review, in compliance with the Paperwork Reduction Act (44 U.S.C. Chapter 35). To request a copy of these documents, call the SAMHSA Reports Clearance Officer on (240) 276–1243. Project: Methamphetamine Use Prevention Initiative—NEW Prevention of Methamphetamine Abuse grants are authorized under Section 519E of the Public Health Service Act, as amended. This program addresses the growing problem of methamphetamine abuse and addiction by assisting localities to expand prevention interventions that are effective and evidence-based and/or to increase capacity through infrastructure development. According to the 2005 National Survey on Drug Use and Health, 10.4 million Americans age 12 and older had tried methamphetamine at least once in their lifetime. In addition, the number of methamphetamine users who were dependent on or abused some kind of illicit drug rose significantly from 164,000 in 2002 to 257,000 in 2005. The goal of the Methamphetamine Abuse Prevention grants is to intervene effectively to prevent, reduce, or delay the use and/or spread of methamphetamine abuse. Proposed Methamphetamine Prevention and Abuse grants will focus on conducting community-based prevention programs targeting those populations within the community that are most at risk for methamphetamine abuse and addiction. In addition, grants may be used for assisting local government entities to conduct appropriate methamphetamine prevention activities in rural and urban areas that are experiencing increases in methamphetamine abuse and addiction. This can be documented by local and E:\FR\FM\02JNN1.SGM 02JNN1 31496 Federal Register / Vol. 73, No. 106 / Monday, June 2, 2008 / Notices specific epidemiological, health service use, judicial and/or environmental data. Activities may include: Training and educating state and local law enforcement officials, prevention and education officials, members of community anti-drug coalitions, and parents on the signs of methamphetamine abuse and addiction and the options for prevention; planning, administration, and educational activities related to the prevention of methamphetamine abuse and addiction; monitoring and evaluating of methamphetamine prevention activities, and reporting and disseminating resulting information to the public; or conducting and evaluating targeted pilot programs. The grantees will be collecting data on the approved National Outcomes Measures (NOMs) —OMB No. 0930– 0230—and program specific questions on youth and adults Methamphetamine use. There are two surveys: One for adults ages 18 and older and another for youths under the age of 18. The adult and youth surveys contain 40 and 42 questions respectively with the first 12 questions covering the OMB approved NOMs questions. The focus areas for the adult surveys comprise of attitudes toward tobacco, alcohol, and other substances; attitudes and experiences; family relationships, relationships with those around you; future goals; thoughts, beliefs, and experiences related to methamphetamines; and thoughts on possible effects of methamphetamine use. The youth survey focus areas include: General information; attitudes toward tobacco, alcohol, and other substances; attitudes and experiences; family relationships; school experiences; perceived probability to try substances; where they receive substance abuse information; thoughts, beliefs, and experiences relating to methamphetamine; effects of methamphetamine use; and how comfortable they were with answering the survey questions. Additional nonmethamphetamine related questions are included to identify risk and protective factors for methamphetamine. These questions identify demographic information which will be useful in categorizing results. Some program specific questions were suggested and agreed upon by the grantees in the review of the survey. All applicants must describe their evaluation plans in their applications, and funded grantees are required to conduct an evaluation of their projects. The evaluation should be designed to provide regular feedback in order to facilitate project improvements. The evaluation must include both process and outcome components which must measure change relating to project goals and objectives over time compared to baseline information. Control or comparison groups are not required. Applicants must consider their evaluation plans when preparing the project budget. The grantees will collect data from program participants at three time periods: Baseline, exit, and 6month follow-up. Each Number of respondents Survey Methamphetamine grantee will collect program specific questions in addition to NOM questions. Similar to the submission process for the Government Performance and Results Act (GPRA), grantees will submit their NOM–Meth data to their respective program Project Officers as well as to the Center for Substance Abuse Prevention’s (CSAP) Data Coordination and Consolidation Center (DCCC) two times per year. The OMB approved NOMs incorporate the GPRA measures for reporting and are approved for all PRNS. DCCC will be responsible for data collection and analysis across grantee sites, while individual grantees will be responsible for their own analyses. The burden is greatly reduced by the fact that the data collection process can be conducted by submitting electronic files. In many cases, some programs can collect all data online. The SAMHSA Prevention Platform has publicly available online data collection and reporting tools such as the database builder, which can be used to meet these reporting requirements. Other tools are under development. CSAP is currently developing a web-based data entry tool that will assist grantees in submitting their data electronically. This data entry tool will reduce the burden on those grantees that do not yet have the capacity to submit large batch files. The DCCC will use this data for secondary analysis that will aid CSAP in responding to GPRA, Office of National Drug Control Policy as well as other federal reporting requirements. Responses per respondent Hours per response Total Burden Hours 3,000 2,400 1,680 1 1 1 .83 .83 .83 2,500 2,000 1,400 Total .......................................................................................... jlentini on PROD1PC65 with NOTICES Baseline Survey ............................................................................... Exiting Survey .................................................................................. 6 month follow up survey ................................................................ 7,080 ............................ ............................ 5,900 Written comments and recommendations concerning the proposed information collection should be sent by July 2, 2008 to: SAMHSA Desk Officer, Human Resources and Housing Branch, Office of Management and Budget, New Executive Office Building, Room 10235, Washington, DC 20503; due to potential delays in OMB’s receipt and processing of mail sent through the U.S. Postal Service, respondents are encouraged to submit comments by fax to: 202–395–6974. Dated: May 23, 2008. Elaine Parry, Acting Director, Office of Program Services. [FR Doc. E8–12177 Filed 5–30–08; 8:45 am] DEPARTMENT OF HOMELAND SECURITY Federal Emergency Management Agency BILLING CODE 4162–20–P [Docket ID FEMA–2007–0008] National Advisory Council Teleconference Federal Emergency Management Agency, DHS. ACTION: Notice of teleconference meeting. AGENCY: SUMMARY: The National Advisory Council (NAC) will be holding a teleconference on June 18, 2008 from 1– VerDate Aug<31>2005 19:06 May 30, 2008 Jkt 214001 PO 00000 Frm 00072 Fmt 4703 Sfmt 4703 E:\FR\FM\02JNN1.SGM 02JNN1

Agencies

[Federal Register Volume 73, Number 106 (Monday, June 2, 2008)]
[Notices]
[Pages 31495-31496]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-12177]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Agency Information Collection Activities: Submission for OMB 
Review; Comment Request

    Periodically, the Substance Abuse and Mental Health Services 
Administration (SAMHSA) will publish a summary of information 
collection requests under OMB review, in compliance with the Paperwork 
Reduction Act (44 U.S.C. Chapter 35). To request a copy of these 
documents, call the SAMHSA Reports Clearance Officer on (240) 276-1243.

Project: Methamphetamine Use Prevention Initiative--NEW

    Prevention of Methamphetamine Abuse grants are authorized under 
Section 519E of the Public Health Service Act, as amended. This program 
addresses the growing problem of methamphetamine abuse and addiction by 
assisting localities to expand prevention interventions that are 
effective and evidence-based and/or to increase capacity through 
infrastructure development. According to the 2005 National Survey on 
Drug Use and Health, 10.4 million Americans age 12 and older had tried 
methamphetamine at least once in their lifetime. In addition, the 
number of methamphetamine users who were dependent on or abused some 
kind of illicit drug rose significantly from 164,000 in 2002 to 257,000 
in 2005. The goal of the Methamphetamine Abuse Prevention grants is to 
intervene effectively to prevent, reduce, or delay the use and/or 
spread of methamphetamine abuse.
    Proposed Methamphetamine Prevention and Abuse grants will focus on 
conducting community-based prevention programs targeting those 
populations within the community that are most at risk for 
methamphetamine abuse and addiction. In addition, grants may be used 
for assisting local government entities to conduct appropriate 
methamphetamine prevention activities in rural and urban areas that are 
experiencing increases in methamphetamine abuse and addiction. This can 
be documented by local and

[[Page 31496]]

specific epidemiological, health service use, judicial and/or 
environmental data. Activities may include: Training and educating 
state and local law enforcement officials, prevention and education 
officials, members of community anti-drug coalitions, and parents on 
the signs of methamphetamine abuse and addiction and the options for 
prevention; planning, administration, and educational activities 
related to the prevention of methamphetamine abuse and addiction; 
monitoring and evaluating of methamphetamine prevention activities, and 
reporting and disseminating resulting information to the public; or 
conducting and evaluating targeted pilot programs.
    The grantees will be collecting data on the approved National 
Outcomes Measures (NOMs) --OMB No. 0930-0230--and program specific 
questions on youth and adults Methamphetamine use. There are two 
surveys: One for adults ages 18 and older and another for youths under 
the age of 18. The adult and youth surveys contain 40 and 42 questions 
respectively with the first 12 questions covering the OMB approved NOMs 
questions. The focus areas for the adult surveys comprise of attitudes 
toward tobacco, alcohol, and other substances; attitudes and 
experiences; family relationships, relationships with those around you; 
future goals; thoughts, beliefs, and experiences related to 
methamphetamines; and thoughts on possible effects of methamphetamine 
use. The youth survey focus areas include: General information; 
attitudes toward tobacco, alcohol, and other substances; attitudes and 
experiences; family relationships; school experiences; perceived 
probability to try substances; where they receive substance abuse 
information; thoughts, beliefs, and experiences relating to 
methamphetamine; effects of methamphetamine use; and how comfortable 
they were with answering the survey questions. Additional non-
methamphetamine related questions are included to identify risk and 
protective factors for methamphetamine. These questions identify 
demographic information which will be useful in categorizing results. 
Some program specific questions were suggested and agreed upon by the 
grantees in the review of the survey.
    All applicants must describe their evaluation plans in their 
applications, and funded grantees are required to conduct an evaluation 
of their projects. The evaluation should be designed to provide regular 
feedback in order to facilitate project improvements. The evaluation 
must include both process and outcome components which must measure 
change relating to project goals and objectives over time compared to 
baseline information. Control or comparison groups are not required. 
Applicants must consider their evaluation plans when preparing the 
project budget. The grantees will collect data from program 
participants at three time periods: Baseline, exit, and 6-month follow-
up. Each Methamphetamine grantee will collect program specific 
questions in addition to NOM questions. Similar to the submission 
process for the Government Performance and Results Act (GPRA), grantees 
will submit their NOM-Meth data to their respective program Project 
Officers as well as to the Center for Substance Abuse Prevention's 
(CSAP) Data Coordination and Consolidation Center (DCCC) two times per 
year. The OMB approved NOMs incorporate the GPRA measures for reporting 
and are approved for all PRNS. DCCC will be responsible for data 
collection and analysis across grantee sites, while individual grantees 
will be responsible for their own analyses.
    The burden is greatly reduced by the fact that the data collection 
process can be conducted by submitting electronic files. In many cases, 
some programs can collect all data online. The SAMHSA Prevention 
Platform has publicly available online data collection and reporting 
tools such as the database builder, which can be used to meet these 
reporting requirements. Other tools are under development. CSAP is 
currently developing a web-based data entry tool that will assist 
grantees in submitting their data electronically. This data entry tool 
will reduce the burden on those grantees that do not yet have the 
capacity to submit large batch files. The DCCC will use this data for 
secondary analysis that will aid CSAP in responding to GPRA, Office of 
National Drug Control Policy as well as other federal reporting 
requirements.

----------------------------------------------------------------------------------------------------------------
                                              Number of       Responses per       Hours per       Total Burden
                 Survey                      respondents       respondent         response            Hours
----------------------------------------------------------------------------------------------------------------
 Baseline Survey........................             3,000                 1               .83             2,500
Exiting Survey..........................             2,400                 1               .83             2,000
6 month follow up survey................             1,680                 1               .83             1,400
                                         -----------------------------------------------------------------------
    Total...............................             7,080  ................  ................             5,900
----------------------------------------------------------------------------------------------------------------

    Written comments and recommendations concerning the proposed 
information collection should be sent by July 2, 2008 to: SAMHSA Desk 
Officer, Human Resources and Housing Branch, Office of Management and 
Budget, New Executive Office Building, Room 10235, Washington, DC 
20503; due to potential delays in OMB's receipt and processing of mail 
sent through the U.S. Postal Service, respondents are encouraged to 
submit comments by fax to: 202-395-6974.

    Dated: May 23, 2008.
Elaine Parry,
Acting Director, Office of Program Services.
 [FR Doc. E8-12177 Filed 5-30-08; 8:45 am]
BILLING CODE 4162-20-P